QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial transparency, and supporting the Company’s next phase of strategic growth.

Executive Appointments

Effective October 2, 2025, Jerry (Jiawei) Wang was appointed as Co-Chief Executive Officer, and Koti Meka was appointed as Chief Financial Officer of Qualigen Therapeutics.

Mr. Wang is the Global President and one of the original founding team members of Faraday Future and was deeply involved in strategic development from its inception starting from 2014, including successfully raising more than $3 billion funding, and led the successful initial public offering (IPO) in 2021.

Mr. Meka is the CFO of Faraday Future. Prior to joining Faraday Future in February 2016, Meka worked at Ford Motor Company from July 2002 to February 2016 in cost optimization, product development finance and corporate finance.

Their appointments underscore the Company’s commitment to building a globally oriented management team with deep operational and financial expertise.

Board of Directors Expansion and Changes

In connection with the Company’s recently closed private placement on September 29, 2025, Qualigen’s Board of Directors appointed three new members:
• Kevin Chen, Independent Director (appointed September 26, 2025)
• Chad Chen, Director
• Jay Sheng, Director

The Board also appointed:
• Jay Sheng as Chairman of the Audit Committee;
• Graydon Bensler and Chad Chen as members of the Audit Committee; and
• Chad Chen, Kevin Chen, and Jay Sheng as members of both the Nominating & Corporate Governance Committee and the Compensation Committee.

Mr. Sheng, is currently the board member of Faraday Future, and the Head of Operations & Finance Director of FF Global Partners LLC, a position he has held since June 2022. From October 2018 to June 2022, Mr. Sheng served as Deputy Managing Director of China Aviation Fuel (Europe) Limited, a wholly owned subsidiary of China Aviation Oil (Singapore) Corporation (“CAO”), a Singapore Exchange-listed Company and a subsidiary of a Fortune 500 Company.